Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 128 results for "zydus cadila"

Cadila Healthcare up 4% on USFDA approval for Itraconazole capsules
Money Control

Zydus Cadila gets USFDA's nod for Desoximetasone ointment

Zydus Cadila has received the final approval from the USFDA to market Desoximetasone Ointment USP, 0.25% . Desoximetasone Ointment is used in relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The drug will be ... Myiris, 1 day ago
[x]  

23 images for zydus cadila

Money Control, 6 days ago
Money Control, 4 weeks ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 2 months ago
Money Control, 2 months ago
Money Control, 2 months ago
Money Control, 3 months ago
Money Control, 2 months ago

Zydus and Pharm Aid tie up for vaccine technology for Russia

Cadila Healthcare Limited (Zydus Cadila), has entered into an exclusive agreement for the technology know-how for varicella vaccine production in the Russian Federation with Pharm Aid Ltd, headquartered in Russia. Pharm Aid Ltd, has been set up by Nacimbio ...
 Business Standard2 days ago Zydus Cadila plans to enter into long-term arrangement with Phibro  Myiris2 months ago Phibro Animal Health to license poultry vaccine tech to Zydus  DNA2 months ago Phibro Animal Health Corporation and Zydus Cadila plan a long term agreement  Business Standard2 months ago
Money Control

Zydus settles patent case over Aptalis' drug Canasa

Zydus group firm Cadila Healthcare today said patent litigation relating to Aptalis' drug Canasa used for treatment of ulcerative colitis has been settled. As a result of the settlement, the company's "US subsidiary, Zydus Pharmaceuticals (USA) Inc, will be ...
 Business Standard1 month ago
Money Control

Zydus Cadila launches anti-ulcer drug in US

Zydus Cadila has launched mesalamine delayed release tablets, used for the treatment of ulcerative colitis, in the US market. "Zydus Cadila has commercially launched its mesalamine delayed release tablets in the US market. Zydus was the first to file an ...
 Business Standard2 months ago Zydus launches Mesalamine Delayed Release tablets in US market  Money Control2 months ago Zydus Cadila launches Mesalamine delayed release tablets in US  Myiris2 months ago

Cadila Healthcare Q1 PAT down 30% as GST hurts domestic business

Cadila Healthcare (or Zydus Cadila) posted a 30 per cent year on year (YoY) drop in standalone net profit for the quarter ended June 30, 2017 to Rs 91.4 crore, while its sales grew by 14 per cent to Rs 1000.4 crore.For the first quarter of the current ...
 Business Standard1 month ago Zydus Cadila's Q1 consolidated net profit up 15%  Prokerala1 month ago
Money Control

Zydus starts phase II trials of molecule targeting anaemia

Drug firm Zydus Cadila today announced the initiation of a phase II trial of oral small molecule Zyan1 that has been designed for the treatment of anaemia associated with chronic kidney disease.
 DNA2 months ago
Money Control

USFDA gives nod to Zydus Cadila's overactive bladder tablets

The US Food and Drug Administration (USFDA) has given final approval to drug firm Zydus Cadila to market oxybutynin chloride tablets used to treat symptoms of overactive bladder and urinary incontinence.
 DNA2 months ago USFDA gives nod to Zydus Cadila#39;s overactive bladder tablets  Money Control2 months ago

'Some gaps in the emerging markets portfolio, but not very significant'

Pankaj R Patel is passing on the baton of Zydus Cadila to his 38-year-old son Sharvil Patel
 Business Standard2 months ago

Of Cadila Healthcare, ICICI Lombard IPO & Other Top Cues in Action Today

Posted by Equitymaster Indian share markets continued to trade flat in Friday's session as geopolitical tensions escalated in far east following another missile launch by North Korea that dampened the sentiment . Even so, Indian markets put up their best ...
 Equitymaster.com4 days ago US Fed Meet, SBI Life IPO and Other Top Cues in Action Today  Equitymaster.com2 days ago

Flat Finish to the Week; Cadila Healthcare Rallies 7%

Posted by Equitymaster Indian share markets finished marginally higher for the week in a thin trade amid buying in pharma stocks , software stocks and capital good stocks . At the closing bell, the BSE Sensex closed higher by 28 points and the NSE Nifty ...
 Equitymaster.com4 weeks ago Indian Indices Continue Momentum; Metal Sector Up 2.3%  Equitymaster.com3 weeks ago Sensex Finishes Over 240 Points Higher; Metal & Healthcare Stocks Gain Most  Equitymaster.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less